Diffuse Intrinsic Pontine Glioma — Trials

Diffuse Intrinsic Pontine Glioma — Trials · CancerIndex

Clinical trials

Registered studies

111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 25
Ph III recruiting: 1
Growth YoY: —
Industry share: 15%
Top sponsor: Nationwide Children's Hospital
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06838676	ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas	recruiting	Phase 2	60	Nationwide Children's HospitalOTHER	5	Sep 21, 2026	clinicaltrials
NCT04870944	CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma	recruiting	Phase 1 / Phase 2	63	Children's Oncology GroupNETWORK	2	Sep 11, 2026	clinicaltrials